DOI QR코드

DOI QR Code

Synthesis and Biological Evaluation of Furo[2,3-d]pyrimidines as Akt1 Kinase Inhibitors

  • Kim, Se-Young (Life Sciences Research Division, Korea Institute of Science and Technology) ;
  • Kim, Dong-Jin (Life Sciences Research Division, Korea Institute of Science and Technology) ;
  • Yang, Beom-Seok (Life Sciences Research Division, Korea Institute of Science and Technology) ;
  • Yoo, Kyung-Ho (Life Sciences Research Division, Korea Institute of Science and Technology)
  • Published : 2007.07.20

Abstract

Based on the hit compound 4 derived from focused library, a series of furo[2,3-d]pyrimidines were designed, synthesized and evaluated for the inhibitory activity against Akt1 kinase. And their structure-activity relationships were investigated. Of these compounds, 3a having 2-thienyl and methyl groups at R1 and R2 showed the most potent activity with an IC50 value of 24 μ M. Introduction of the thienyl groups at C-5 and C- 6 positions significantly improved potency compared to furyl and phenyl groups.

Keywords

References

  1. Barnett, F. S.; Bilodeau, M. T.; Lindsley, C. W. Curr. Top. Med. Chem. 2005, 5, 109 https://doi.org/10.2174/1568026053507714
  2. Bellacosa, A.; Kumar, C. C.; Di Cristofano, A.; Testa, J. R. Adv. Cancer. Res. 2005, 94, 29 https://doi.org/10.1016/S0065-230X(05)94002-5
  3. Mitsiades, C. S.; Mitsiades, N.; Koutsilieris, M. Curr. Cancer Drug Targets 2004, 4, 235 https://doi.org/10.2174/1568009043333032
  4. Nakatani, K.; Thompson, D. A.; Barthel, A.; Sakaue, H.; Liu, W.; Weigel, R. J.; Roth, R. A. J. Biol. Chem. 1999, 274, 21528 https://doi.org/10.1074/jbc.274.31.21528
  5. Blume-Jensen, P.; Hunter, T. Nature (Lond.) 2001, 411, 355
  6. Thomas, S. A.; Li, T.; Woods, K. W.; Song, X.; Packard, G.; Fisher, J. P.; Diebold, R. B.; Liu, X.; Shi, Y.; Klinghofer, V.; Johnson, E. F.; Bouska, J. J.; Olson, A.; Guan, R.; Magnone, S. R.; Marsh, K.; Luo, Y.; Rosenberg, S. H.; Giranda, V. L.; Li, Q. Bioorg. Med. Chem. Lett. 2006, 16, 3740 https://doi.org/10.1016/j.bmcl.2006.04.046
  7. Zhao, Z.; Leister, W. H.; Robinson, R. G.; Barnett, S. F.; Defeo- Johns, D.; Jones, R. E.; Hartman, G. D.; Huff, J. R.; Huber, H. E.; Duggan, M. E.; Lindsley, C. W. Bioorg. Med. Chem. Lett. 2005, 15, 905 https://doi.org/10.1016/j.bmcl.2004.12.062
  8. Barnett, S. F.; Defeo-Jones, D.; Haskell, K. M.; Huber, H. E.; Nahas, D. D.; Lindsley, C. W.; Zhao, Z.; Hartman, G. D. WO 084473, 2003
  9. Gewald, K. Chem. Ber. 1966, 99, 1002 https://doi.org/10.1002/cber.19660990340
  10. Feng, X.; Lancelot, J.; Prunier, H.; Rault, S. J. Heterocycl. Chem. 1996, 33, 2007 https://doi.org/10.1002/jhet.5570330671
  11. Prousek, J.; Jurasek, A.; Kovac, J. Collection Czechoslov. Chem. Commun. 1980, 45, 1581 https://doi.org/10.1135/cccc19801581
  12. Doyle, K. M.; Kurzer, F. Tetrahedron 1976, 32, 2347 https://doi.org/10.1016/0040-4020(76)88013-1
  13. Miyashita, A.; Obae, K.; Suzuki, Y.; Oishi, E.; Iwamoto, K.; Higashino, T. Heterocycles 1997, 45, 2159 https://doi.org/10.3987/COM-97-7914
  14. Nielsen, F. E.; Pedersen, E. B. Tetrahedron 1982, 38, 1435 https://doi.org/10.1016/0040-4020(82)80226-3
  15. Girgis, S.; Pedersen, B.; Synth. Commun. 1982, 480
  16. Doyle, P.; Siegfried, B.; Dellaria, F. J. Org. Chem. 1977, 42, 2426 https://doi.org/10.1021/jo00434a017
  17. Ku, H.; Barrio, R. J. Org. Chem. 1981, 46, 5239 https://doi.org/10.1021/jo00338a044
  18. Ram, V. J.; Pandey, H. K. J. Heterocycl. Chem. 1981, 18, 1277
  19. Kumar, C. C.; Diao, R.; Yin, Z.; Liu, Y.; Samatar, A. A.; Madison, V.; Xiao, L. Biochim. Biophys. Acta 2001, 1526, 257 https://doi.org/10.1016/S0304-4165(01)00143-X

Cited by

  1. Chromone-Fused Cytosine Analogues: Synthesis, Biological Activity, and Structure–Activity Relationship vol.33, pp.2, 2014, https://doi.org/10.1080/15257770.2013.873128
  2. -one Derivatives vol.2017, pp.2090-9071, 2017, https://doi.org/10.1155/2017/5610707
  3. Synthesis and Biological Evaluation of Furo[2,3-d]pyrimidines as Akt1 Kinase Inhibitors. vol.38, pp.49, 2007, https://doi.org/10.1002/chin.200749171
  4. One-Pot Synthesis of Substituted 2-Amino-3-Furonitriles vol.2008, pp.10, 2008, https://doi.org/10.3184/030823408x356314
  5. Novel method for the synthesis of furo[2,3-d]Pyrimidines by cyclization of 4-(phenacyloxy)pyrimidine-5-carbonitriles vol.46, pp.3, 2007, https://doi.org/10.1007/s10593-010-0520-3
  6. An Efficient Synthesis of Novel Chromone-Containing Furopyrimidines vol.35, pp.9, 2007, https://doi.org/10.3184/174751911x13146322603355
  7. A facile domino protocol for the stereoselective synthesis of trans-2,3-dihydrobenzofurans and cis-5,6-dihydrofuro[2,3-d]pyrimidines vol.53, pp.8, 2007, https://doi.org/10.1016/j.tetlet.2011.12.047
  8. Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents vol.2, pp.1, 2007, https://doi.org/10.1016/j.fjps.2015.12.001